Metastatic Breast Cancer
Conference Coverage
Whole breast radiation for breast cancer shown to be safe and effective
Whole breast radiation can cut treatment time from 6 weeks down to 3 weeks.
Opinion
Discontinuing immunotherapy: Is the infusion bag half empty or half full?
Clinical trials of immunotherapy or chemoimmunotherapy have generally terminated treatment in nonprogressing patients after 2 years.
Conference Coverage
How AI is, or will soon be, relevant in radiation oncology
Radiation oncologists at ASTRO 2022 discuss practical applications of AI, and new research findings.
News
Chronic stress, especially race related, may hasten cancer death
High allostatic load was associated with an 80% increased risk of cancer death among all study participants.
News
Third COVID booster benefits cancer patients
For the first time, researchers have quantified the benefits of boosters for COVID-19 in cancer patients.
Conference Coverage
Findings may be practice changing for early breast cancer patients
A radiation boost to the tumor bed during whole breast irradiation was as safe and effective as delivering the boost sequentially.
News
Study affirms better breast cancer outcomes when chemo comes first
Survival is better when high-risk breast cancer patients receive chemo first, followed by abemaciclib and estrogen therapy.
Opinion
Cancer as a full contact sport
The complexity of cancer care has long necessitated a team approach to planning cancer treatment.
News
Cost paramount when choosing metastatic breast cancer treatment
“Our analysis provides quantifiable evidence to help providers choose lower priced, but equally effective sequences of drugs.”
News
FDA OKs selpercatinib for adults with RET-fusion+ solid tumors
In 2020, selpercatinib received accelerated approval for lung and thyroid RET-positive tumors.